K. Kalnin

Most-cited papers

1. Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza

   Sudha Chivukula, T. Plitnik, T. Tibbitts, S. Karve +26 more

   2021npj Vaccines104 citations Open access

   Semantic Scholar

   Save

2. Phosphatidylcholine-Specific Phospholipase C and Sphingomyelinase Activities in Bacteria of the Bacillus cereus Group

   A. Pomerantsev, K. Kalnin, M. Osório, S. Leppla

   2003Infection and Immunity85 citations Open access

   Semantic Scholar

   Save

3. Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models

   K. Kalnin, T. Plitnik, Michael Kishko, Jin-Rong Zhang +34 more

   2021npj Vaccines80 citations Open access

   Semantic Scholar

   Save

4. pTAR-Encoded Proteins in Plasmid Partitioning

   K. Kalnin, Svetlana S. Stegalkina, M. Yarmolinsky

   2000Journal of Bacteriology46 citations Open access

   Semantic Scholar

   Save

5. Low doses of flagellin-L2 multimer vaccines protect against challenge with diverse papillomavirus genotypes

   K. Kalnin, T. Tibbitts, Yan-Hua Yan, Svetlana S. Stegalkina +11 more

   2014Vaccine45 citations Open access

   Semantic Scholar

   Save

6. Phylogenetic Considerations in Designing a Broadly Protective Multimeric L2 Vaccine

   Subhashini Jagu, Kihyuck Kwak, J. Schiller, D. Lowy +9 more

   2013Journal of Virology35 citations Open access

   Semantic Scholar

   Save

7. Understanding structure activity relationships of Good HEPES lipids for lipid nanoparticle mRNA vaccine applications.

   R. Goldman, Namratha Turuvekere Vittala Murthy, Trent P. Northen, A. Balakrishnan +15 more

   2023Biomaterials24 citations Open access

   Semantic Scholar

   Save

8. Incorporation of RG1 epitope concatemers into a self-adjuvanting Flagellin-L2 vaccine broaden durable protection against cutaneous challenge with diverse human papillomavirus genotypes

   K. Kalnin, Sudha Chivukula, T. Tibbitts, Yan-Hua Yan +10 more

   2017Vaccine21 citations Open access

   Semantic Scholar

   Save

9. Immunogenicity of novel mRNA COVID-19 vaccine MRT5500 in mice and non-human primates

   K. Kalnin, T. Plitnik, Michael Kishko, Jin-Rong Zhang +23 more

   2020bioRxiv20 citations Open access

   Semantic Scholar

   Save

10. Pan-SARS neutralizing responses after third boost vaccination in non-human primate immunogenicity model

    K. Kalnin, T. Plitnik, Michael Kishko, Dean Huang +25 more

    2022Vaccine10 citations Open access

    Semantic Scholar

    Save

11. Broadly Protective Multimeric L2 Vaccine Phylogenetic Considerations in Designing a

    S. Roden, Sudha Chivukula, Hsu-Kun Wang, Louise T. Chow +5 more

    20140 citations

    Semantic Scholar

    Save

12. Genetic and molecular R-plasmid analysis of Enterobacteriaceae hospital strains at Children's Hospitals of the former USSR.

    L. Glatman, K. Kalnin, N. V. Klitsunova, T. I. Domoradskaya +4 more

    1994Journal of chemotherapy0 citations

    Semantic Scholar

    Save

13. [The incidence of finding and characteristics of Klebsiella pneumoniae strains isolated in neonatal infections].

    L. A. Berezina, G. Tseneva, S. G. Boikov, K. Kalnin +1 more

    1993Zhurnal mikrobiologii, epidemiologii, i immunobiologii0 citations

    Semantic Scholar

    Save

14. [The resistance plasmid of Klebsiella pneumoniae that controls its cytotoxic activity].

    K. Kalnin, L. Glatman, V. M. Bondarenko, L. A. Berezina +2 more

    1992Zhurnal mikrobiologii, epidemiologii, i immunobiologii0 citations

    Semantic Scholar

    Save

15. [A new site-specific endodeoxyribonuclease EcoHI].

    L. Glatman, A. Terekhov, K. Kalnin, A. Bolotin +1 more

    1990Molecular Genetics Microbiology and Virology (Russian version)0 citations

    Semantic Scholar

    Save

16. [The role of R plasmids in the resistance of bacteria in air].

    V. F. Koniukhov, L. I. Likhoded, L. Glatman, K. Kalnin

    1987Zhurnal mikrobiologii, epidemiologii, i immunobiologii0 citations

    Semantic Scholar

    Save